主要論文
-
"Effectiveness of polymyxin B hemoperfusion for sepsis depends on the baseline SOFA score: a nationwide observational study."Fujimori K et al. Ann Intensive Care (2021) 11:141
PubMed -
"Effects of Polymyxin B Hemoperfusion on Septic Shock Patients Requiring Noradrenaline: Analysis of a Nationwide Administrative Database in Japan."Fujimori K et al. Blood Purification (2021) 50:560-5
PubMed -
"Effects of endotoxin adsorber hemoperfusion on sublingual microcirculation in patients with septic shock: a randomized controlled trial." Chen SH et al. (2020) Ann Intensive Care 10:80
PubMed -
"Polymyxin B hemoperfusion in endotoxemic septic shock patients without extreme endotoxemia: a post hoc analysis of the EUPHRATES trial." Klein DJ et al. Intensive Care Med (2018) Nov. 23
PubMed -
"The effect of polymyxin B hemoperfusion on modulation of human leukocyte antigen DR in severe sepsis patients." Srisawat N et al. Crit Care (2018) 22:279
PubMed -
"Effect of Targeted Polymyxin B Hemoperfusion on 28-Day Mortality in Patients With Septic Shock and Elevated Endotoxin Level: The EUPHRATES Randomized Clinical Trial.." Dellinger RP et al. JAMA (2018) 320:1455-63
PubMed -
"Polymyxin B-immobilized hemoperfusion and mortality in critically ill adult patients with sepsis/septic shock: a systematic review with meta-analysis and trial sequential analysis." Fujii T et al. Intensive Care Med (2018) 44:167-78
PubMed -
"Potential survival benefit of polymyxin B hemoperfusion in patients with septic shock: a propensity-matched cohort study." Nakamura Y et al. Crit Care (2017) 21:134
PubMed -
"Effects of Polymyxin B Hemoperfusion on Mortality in Patients With Severe Sepsis and Septic Shock: A Systemic Review, Meta-Analysis Update, and Disease Severity Subgroup Meta-Analysis." Chang T et al. Crit Care Med (2017) 45:e858-e864
PubMed -
"Polymyxin B Hemoperfusion for Sepsis and Septic Shock: A Systematic Review and Meta-Analysis. "Terayama T et al. Surg Infect (2017) 18:225-33
PubMed -
"Polymyxin-B hemoperfusion in septic patients: analysis of a multicenter registry." Cutuli SL et al. Ann Intensive Care (2016) 6:77
PubMed -
"Potential Survival Benefit of Polymyxin B Hemoperfusion in Septic Shock Patients on Continuous Renal Replacement Therapy: A Propensity-Matched Analysis." Iwagami M et al. Blood Purif (2016) 42:9-17
PubMed -
"Early use of polymyxin B hemoperfusion in patients with septic shock due to peritonitis: a multicenter randomized control trial." Payen D et al. Intensive Care Med (2015) 41:975-84
PubMed -
"Rescue therapy with Polymyxin B hemoperfusion in high dose vasopressor therapy Refractory Septic Shock." Monti G et al. Minerva Anestesiol (2015) 81:516-2
PubMed -
"Endotoxin adsorption using polymyxin B immobilized fiber cartridges in severe sepsis patients following cardiac surgery." Yaroustovsky M et al. Int J Artif Organs (2014) 37:299-307
PubMed -
"Postoperative Polymyxin B Hemoperfusion and Mortality in Patients With Abdominal Septic Shock: A Propensity-Matched Analysis." Iwagami M et al. Crit Care Med (2013) 42:1187-93
PubMed -
"Blood Purification and Mortality in Sepsis:A Meta-analysis of Randomized Trials." Zhou F et al. Crit Care Med (2013) 41:2209-2220
PubMed -
"Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial." Cruz DN et al. JAMA (2009) 301:2445-52
PubMed -
"Polymyxin-B hemoperfusion inactivates circulating proapoptotic factors." Cantaluppi V et al. Intensive Care Med (2008) 34:1638-45
PubMed -
"Effectiveness of polymyxin B-immobilized fiber column in sepsis: a systematic review." Cruz DN et al. Crit Care (2007) 11:R47
PubMed -
"A pilot-controlled study of a polymyxin B-immobilized hemoperfusion cartridge in patients with severe sepsis secondary to intra-abdominal Infection." Vincent JL et al. Shock (2005) 23:400-5
PubMed